fluorodeoxyglucose f18 has been researched along with Glioblastoma in 132 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (3.79) | 18.7374 |
| 1990's | 22 (16.67) | 18.2507 |
| 2000's | 32 (24.24) | 29.6817 |
| 2010's | 53 (40.15) | 24.3611 |
| 2020's | 20 (15.15) | 2.80 |
| Authors | Studies |
|---|---|
| Glenn, CA; Javan, R; Johnson, DR; Olson, JJ | 1 |
| Doi, H; Hume, WE; Ishii, A; Mawatari, A; Nakatani, Y; Nozaki, S; Tanaka, M; Tsuyuguchi, N; Wada, Y; Watanabe, Y | 1 |
| Das, SS; Khanna, G; Malik, D; Patir, R; Sen, IB | 1 |
| Cao, X; Chen, S; Kan, Y; Liao, M; Liao, R; Liu, Z; Nie, L; Tan, D; Xie, M; Yao, R; Zhang, L | 1 |
| Derlon, JM; Gourand, F; Guillouet, S; Kalaeva, D; Khokholova, E; Kobyakov, G; Maryashev, S; Pitskhelauri, D; Postnov, A; Potapov, A; Pronin, I; Pyzhik, E; Rizhova, M; Toutain, J; Usachev, D; Valable, S; Vikhrova, N | 1 |
| Bartha, R; Bellyou, M; Desjardins, L; Fox, MS; Hoffman, L; Lee, TY; Li, A; Lim, H; McClennan, A; Qi, Q; Scholl, TJ; Sullivan, R; Thiessen, JD | 1 |
| Honda, T; Inoue, A; Kanno, K; Kinnami, S; Kitazawa, R; Kunieda, T; Kurata, M; Kusakabe, K; Matsumoto, S; Miyazaki, Y; Ohnishi, T; Shigekawa, S; Suehiro, S; Taniwaki, M; Watanabe, H; Yamashita, D | 1 |
| Aryana, K; Kamali, H; Kiamanesh, Z; Mohammadzadeh Kosari, H; Sadeghi, R | 1 |
| Baixeras, N; Pudis, M; Suárez-Piñera, M; Torró, CM; Vilariño, N | 1 |
| Aoki, Y; Han, Q; Hoffman, RM; Hozumi, C; Kubota, Y; Masaki, N; Obara, K; Sato, T; Tsunoda, T | 1 |
| Kuang, A; Ma, H; Pan, L; Shen, G; Su, M | 1 |
| Kay, MD; Kuo, PH; Pariury, HE; Perry, A; Winegar, BA | 1 |
| Du, JX; Li, ZG; Liu, K; Zhang, SW; Zhao, Q; Zheng, MY | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chiang, GC; Ebani, EJ; Meng, A; Strauss, SB | 1 |
| Beinat, C; Chang, E; Gambhir, SS; Patel, CB; Xie, Y | 1 |
| Malik, D | 1 |
| Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Hallaert, G; Van den Broecke, C; Vanhove, C | 1 |
| Hatakeyama, J; Oda, M; Ono, T; Shimizu, H; Takahashi, M | 1 |
| Badve, C; Faulhaber, P; Garg, V; Hojjati, M; Rogers, L; Ros, PR; Sloan, A; Tatsuoka, C; Wolansky, LJ | 1 |
| Hashimoto, N; Kamada, H; Nishio, A; Takahashi, Y; Yamamoto, D | 1 |
| Chi, AS; Cordova, C; Jain, R; Margiewicz, S | 1 |
| Calvo García, M; García Vicente, AM; Perez-Beteta, J; Soriano Castrejón, A; Villena Martín, M | 1 |
| Merabtene, F; Nataf, V; Prignon, A; Provost, C; Rozenblum-Beddok, L; Talbot, JN | 1 |
| Barré, L; Fillesoye, F; Gourand, F; Guillouet, S; Hovhannisyan, N; Ibazizene, M; Plancoulaine, B; Toutain, J; Valable, S | 1 |
| Balasse, L; Bouhlel, A; Ding, L; Fernandez, S; Garrigue, P; Giorgio, S; Guillet, B; Huang, Y; Iovanna, J; Lan, W; Laurini, E; Liu, X; Lyu, Z; Marson, D; Mas, E; Peng, L; Pricl, S; Tang, J; Tintaru, A; Weng, Y; Zhang, M | 1 |
| Beinat, C; Gambhir, SS; Patel, CB; Xie, Y | 1 |
| Burgess, TL; Coxon, A; Gambhir, SS; Glaus, C; Gobalakrishnan, S; Lewis, XZ; Radinsky, R; Rex, K; Silva, MD | 1 |
| Chen, Z; Liu, Y; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Faber, C; Jacobs, AH; Kopka, K; Kuhlmann, M; Schäfers, M; Schelhaas, S; Schwegmann, K; Viel, T; Wachsmuth, L; Wagner, S | 1 |
| Beppu, T; Ehara, S; Fujiwara, S; Iwata, R; Kudo, K; Matsuura, H; Ogasawara, K; Sasaki, M; Sasaki, T; Sera, K; Sugai, T; Takai, Y; Terasaki, K; Uesugi, N; Yamada, N | 1 |
| Belloli, S; Brioschi, A; Calderoni, S; Fazio, F; Mauro, A; Monterisi, C; Moresco, RM; Pagani, A; Politi, LS; Raccagni, I; Ronchetti, F; Zara, G; Zenga, F | 1 |
| Bahri, MA; Blomme, A; Bretin, F; Castronovo, V; Lemaire, C; Libert, LC; Luxen, A; Plenevaux, AR; Seret, AE; Turtoi, A; Warnock, G | 1 |
| Benz, MR; Buck, AK; Chen, W; Cloughesy, T; Czernin, J; Herrmann, K; Lai, A; Phelps, ME; Pomykala, KL | 1 |
| Bentourkia, M; Blanchette, M; Croteau, É; Lebel, R; Lecomte, R; Lepage, M; Poulin, É; Tremblay, L | 2 |
| Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
| Beschorner, R; la Fougère, C; Pichler, B; Reischl, G; Schwenck, J; Skardelly, M; Tabatabai, G | 1 |
| Djaldetti, R; Lotan, I; Luckman, J; Siegal, T; Steiner, I | 1 |
| Fan, D; Jia, B; Liu, X; Liu, Z; Shi, J; Sun, Y; Wang, F; Zhang, X; Zhao, H; Zhong, L; Zhu, Z | 1 |
| de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G | 1 |
| Aaberg-Jessen, C; Andersen, C; Dam, JH; Halle, B; Hvidsten, S; Høilund-Carlsen, PF; Kristensen, BW; Schulz, MK; Thisgaard, H; Thykjær, AS | 1 |
| Aprile, C; Buroni, FE; Lodola, L; Nano, R; Pasi, F; Persico, MG | 1 |
| Chow, PK; Fu, Y; Kee, I; Ong, LC; Ranganath, SH; Wang, CH; Yu, S; Zhan, W; Zheng, L | 1 |
| Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW | 1 |
| Bouttens, F; D'Haene, N; Du Four, S; Duerinck, J; Everaert, H; Le Mercier, M; Michotte, A; Neyns, B; Salmon, I; Van Binst, AM; Vandervorst, F; Verschaeve, V | 1 |
| Baba, S; Hiwatashi, A; Honda, H; Iihara, K; Isoda, T; Iwaki, T; Kikuchi, K; Kitamura, Y; Kuga, D; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K | 1 |
| Chiang, GC; Ferraro, R; Galla, N; Kovanlikaya, I | 1 |
| Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Kalala, JP; Lybaert, K; Moerman, L; Van den Broecke, C; Vanhove, C | 1 |
| de Groot, JF; O'Neill, AF; Qin, L; Van den Abbeele, AD; Wen, PY; Yap, JT | 1 |
| Hattori, N; Hirata, K; Ito, YM; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S | 1 |
| Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
| Flors, L; Leiva-Salinas, C; Patrie, JT; Rehm, PK; Schiff, D | 1 |
| Czernin, J; Hildebrandt, IJ; Phelps, ME; Su, H; Weber, WA; Wei, LH | 1 |
| Imahori, Y; Kajimoto, Y; Kawabata, S; Kirihata, M; Kuroiwa, T; Miyashita, M; Miyatake, S; Ono, K; Otsuki, Y; Shibata, MA; Yokoyama, K | 1 |
| Barrie, M; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Metellus, P; Mundler, O | 1 |
| Kawabe, T; Mineura, K; Miyamoto, J; Owada, K; Sasajima, H; Tatsuzawa, K | 1 |
| Flores, JE; Gill, HS; Greve, JM; Marik, J; Martin-McNulty, B; Nishimura, M; Ogasawara, A; Pastuskovas, C; Peale, F; Ross, J; Tinianow, JN; van Bruggen, N; Vanderbilt, AN; Williams, SP | 1 |
| Cai, L; Chen, QS; Gao, S; Li, DC; Li, YS; Xing, XL | 1 |
| Boy, C; Buell, U; Coenen, HH; Eble, MJ; Ehmer, J; Kaiser, HJ; Piroth, MD; Schaefer, WM; Thiele, F | 1 |
| Buchegger, F; Casanova, N; Dipasquale, G; Miralbell, R; Nouet, P; Ratib, O; Rouzaud, M; Vees, H; Weber, DC; Zilli, T | 1 |
| Higano, S; Iwata, R; Kanamori, M; Kumabe, T; Saito, R; Shibahara, I; Sonoda, Y; Takai, Y; Takanami, K; Tominaga, T; Watanabe, M | 1 |
| Dicker, DT; Dorsey, JF; Dowling, ML; El-Deiry, WS; Kao, GD; Mintz, A; Plastaras, JP; Tian, X | 1 |
| Hasegawa, T; Houkin, K; Minamida, Y; Momota, H; Noguchi, H; Suzuki, K; Tonooka, A; Wanibuchi, M; Yamamoto, K | 1 |
| Beattie, BJ; Blasberg, RG; Holodny, AI; Makeyev, S; Riad, S | 1 |
| Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
| Beer, AJ; Drzezga, A; Kläsner, BD; Krause, BJ | 1 |
| Brown, PD; Buckner, JC; Galanis, E; Giannini, C; Jaeckle, KA; McGraw, S; Peller, PJ; Sarkaria, JN; Uhm, JH; Wu, W | 1 |
| Añaños, M; Calvo, N; Danús, M; Intriago, B; Montero, M; Trampal, C | 1 |
| Akter, M; Hirai, T; Iwashita, K; Kitajima, M; Kuratsu, J; Makino, K; Murakami, R; Nakamura, H; Nakashima, R; Shigematsu, Y; Shiraishi, S; Uetani, H; Yamashita, Y | 1 |
| Amin, M; Chunta, JL; Marples, B; Martinez, AA; Oliver Wong, CY; Park, SS; Robertson, JM; Wilson, GD | 1 |
| Binderup, T; Denholt, CL; Gillings, N; Hansen, PR; Kjær, A; Poulsen, HS; Spang-Thomsen, M; Stockhausen, MT | 1 |
| Arbizu, J; Aristu, JJ; Díez-Valle, R; Domínguez-Prado, I; Garrastachu, P; Martí-Climent, JM; Peñuelas, I; Prieto, E; Tejada, S | 1 |
| Guillevin, R; Noël, G | 1 |
| De Clermont, H; Fernandez, P; Huchet, A; Lamare, F; Rivière, A | 1 |
| Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
| Behe, M; Braun, F; Grosu, AL; Milanović, D; Niedermann, G; Weber, W | 1 |
| Ando, Y; Fujii, M; Kato, K; Maesawa, S; Naganawa, S; Nihashi, T; Okada, Y; Okochi, Y; Takebayashi, S; Wakabayashi, T; Yamashita, M | 1 |
| Abe, K; Hiwatashi, A; Honda, H; Iwaki, T; Kikuchi, K; Maruoka, Y; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K; Yoshiura, T | 1 |
| Barré, L; Bernaudin, M; Corroyer-Dulmont, A; Delamare, J; Divoux, D; Guillamo, JS; Ibazizène, M; Jacobs, AH; Lecocq, M; MacKenzie, ET; Pérès, EA; Petit, E; Roussel, S; Toutain, J; Valable, S; Varoqueaux, N | 1 |
| Campos, C; Carlin, SD; Cheal, SM; Doran, MG; Evans, MJ; Holland, JP; Lewis, JS; Mellinghoff, IK; Rice, SL; Sawyers, CL | 1 |
| Chen, Z; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Douglas, JG; Hummel, S; Krohn, KA; Mankoff, DA; Rostomilly, R; Rostomily, RC; Scharnhorst, J; Silbergeld, DL; Spence, AM; Stelzer, KJ; Tralins, KS | 1 |
| Deichen, JT; Gack, M; Kuwert, T; Prante, O; Schmiedehausen, K | 1 |
| Cheng, X; Dang, YH; Wang, SZ; Zhou, Q | 1 |
| Jawahar, A; Nanda, A; Shorter, C; Stout, N; Weilbaecher, C | 1 |
| Deichen, JT; Hoffmann, M; Kuwert, T; Maschauer, S; Prante, O | 1 |
| Buck, AK; Reske, SN | 1 |
| Bachert, P; Henze, M; Kauczor, HU; Lichy, MP; Plathow, C; Schlemmer, HP | 1 |
| Lewis, PJ; Siegel, A; Siepmann, DB | 1 |
| Börner, AR; Knapp, WH; Mirzayan, MJ; Petrich, T; Samii, A; Samii, M | 1 |
| Armand, JP; Beaudre, A; Bidault, F; Bruna, A; Dhermain, F; Ducreux, D; Haie-Meder, C; Parker, F; Roujeau, T | 1 |
| Momose, T | 1 |
| Douglas, JG; Krohn, KA; Mankoff, DA; Muzi, M; Rostomily, RC; Scharnhorst, J; Silbergeld, DL; Spence, AM; Stelzer, KJ; Tralins, KS | 1 |
| Fischer, BM; Højgaard, L; Klausen, TL; Kristjansen, PE; Ley, CD; Mortensen, J; Olsen, MW | 1 |
| Andersen, PB; Blinkenberg, M; Kosteljanetz, M; Lassen, U; Paulson, OB; Poulsen, HS; Sørensen, PS; Wagner, A | 1 |
| Kim, JS; Ra, YS; Sohn, CH; Won, KS; Zeon, SK | 1 |
| Burd, R; Cardi, C; Daskalakis, C; Dicker, AP; Holash, J; Thakur, M; Wachsberger, PR; Yancopoulos, GD | 1 |
| Asenbaum, S; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Marosi, C; Pötzi, C; Szabo, M | 1 |
| Christensen, JG; Dandekar, M; Gambhir, SS; Kang, KW; Lee, JH; Michaud, NR; Muir, S; Tseng, JR; Vincent, PW; Yaghoubi, S | 1 |
| Fujibayashi, Y; Okazawa, H; Takeuchi, H; Tsuchida, T; Tsujikawa, T | 1 |
| Hatazawa, J; Iida, H; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shioya, H; Uemura, K | 1 |
| Arbit, E; Canete, A; Cheung, NK; Cordon-Cardo, C; Daghighian, F; Finn, R; Larson, SM; Pentlow, K; Yeh, SD; Zhang, JJ | 1 |
| Balériaux, D; Bidaut, LM; Brotchi, J; Brucher, JM; Goldman, S; Levivier, M; Luxen, A; Pirotte, B; Stanus, E | 1 |
| Roelcke, U | 1 |
| Aoki, S; Fujii, H; Kosuda, S; Nakamura, O; Shitara, N; Suzuki, K; Tanaka, Y | 1 |
| Cohen, JD; Hanson, JM; Levine, RL; Mehta, MP; Nickles, RJ; Rozental, JM | 1 |
| Ahmad, K; Endo, K; Hirano, T; Horikoshi, S; Inoue, T; Oriuchi, N; Sarwar, M; Shibasaki, T; Suzuki, H; Tamura, M; Tokunaga, M; Tomiyoshi, K; Watanabe, N | 1 |
| Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC | 1 |
| Brandau, W; Kuwert, T; Lerch, H; Matheja, P; Morgenroth, C; Palkovic, S; Samnick, S; Schäfers, K; Schäfers, M; Schober, O; Vollet, B; Wassmann, H; Woesler, B | 1 |
| Furuta, M; Hasegawa, M; Hayakawa, K; Ishikawa, H; Mitsuhashi, N; Niibe, H; Nonaka, T; Yamakawa, M | 1 |
| Bartenstein, P; Daschner, H; Feldmann, HJ; Gross, MW; Kinzel, D; Lumenta, C; Molls, M; Reidel, G; Schwaiger, M; Weber, W; Ziegler, SI | 1 |
| Gullotta, F; Kuwert, T; Probst-Cousin, S; Schäfers, M; Schober, O; Wassmann, H; Woesler, B | 1 |
| Berger, MS; Freeman, SD; Graham, MM; Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Muzi, M; O'Sullivan, F; Ojemann, GA; Spence, AM | 1 |
| Blasberg, RG; Herrmann, R; Hofer, S; Leenders, KL; Maguire, RP; Radü, EW; Roelcke, U; von Ammon, K; Vontobel, P | 1 |
| Hirano, T; Horikoshi, S; Kurihara, H; Ono, N; Oriuchi, N; Shibasaki, T; Tamura, M; Zama, A | 1 |
| Akabani, G; Brown, MT; Coleman, RE; Hanson, MW; Marriott, CJ; McLendon, RE; Thorstad, W | 1 |
| Bartenstein, P; Feldmann, HJ; Gross, MW; Molls, M; Schwaiger, M; Weber, WA | 1 |
| Fukui, M; Fukumura, T; Kuwabara, Y; Masuda, K; Mihara, F; Morioka, T; Nakagawa, M; Sasaki, M; Yoshida, T | 1 |
| Bader, JB; Feiden, W; Kirsch, CM; Kremp, S; Moringlane, JR; Samnick, S; Schaefer, A | 1 |
| Brock, H; Kozak, B; Oehr, P; Rink, H; Ruhlmann, J; Thieme, D | 1 |
| Biselli, M; Engels, R; Hamacher, K; Langen, KJ; Mühlensiepen, H; Noll, T; Papaspyrou, M | 1 |
| Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG | 1 |
| Brotchi, J; De Witte, O; Goldman, S; Lefranc, F; Levivier, M; Salmon, I | 1 |
| Bader, JB; Feiden, W; Hellwig, D; Kirsch, CM; Moringlane, JR; Romeike, BF; Samnick, S | 1 |
| Meyer, GJ; Schober, O | 1 |
| Alavi, A; Alavi, J; Kramer, E; Wegener, W | 1 |
| Dobkin, JA; Levine, RL; Nickles, RJ; Rozental, JM | 1 |
| Alavi, A; Alavi, JB; Dann, R; Goldberg, HI; Hickey, W; Reivich, M | 1 |
| Budinger, TF; Doyle, WK; Gutin, PH; Levin, VA; Silver, P; Valk, PE | 1 |
| Bairamian, D; Di Chiro, G; Kornblith, PL; Kufta, C; Larson, SM; Patronas, NJ; Simon, R | 1 |
| Kowada, M; Mineura, K; Ogawa, T; Shishido, F; Uemura, K; Yasuda, T | 1 |
11 review(s) available for fluorodeoxyglucose f18 and Glioblastoma
| Article | Year |
|---|---|
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
Topics: Adult; Amino Acids; Brain Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Neurosurgeons; Positron-Emission Tomography; Practice Guidelines as Topic | 2022 |
Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: a case report and literature review.
Topics: Adult; Brain Neoplasms; Cervical Vertebrae; Fatal Outcome; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Treatment Outcome | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Topics: Brain; Brain Neoplasms; Contrast Media; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Necrosis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Treatment Outcome | 2021 |
State of the Art Treatment and Surveillance Imaging of Glioblastomas.
Topics: Angiogenesis Inhibitors; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunotherapy; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature.
Topics: Aged; Brain Neoplasms; Coronary Angiography; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography | 2010 |
PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
Topics: Animals; Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radioactive Tracers | 2010 |
[Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Topics: Brain Neoplasms; Diagnostic Imaging; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2005 |
[Clinical application of positron emission tomography and 18FDG to brain tumor].
Topics: Aged; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2005 |
PET: brain tumor biochemistry.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Blood-Brain Barrier; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Polyamines; Receptors, GABA-A; Tomography, Emission-Computed | 1994 |
[Evaluation of brain tumors using positron emission tomography].
Topics: Astrocytoma; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Humans; Tomography, Emission-Computed | 1992 |
13 trial(s) available for fluorodeoxyglucose f18 and Glioblastoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Pressure | 2014 |
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Axitinib; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Imidazoles; Indazoles; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Radiopharmaceuticals; Steroids; Treatment Outcome; Young Adult | 2016 |
Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A | 2016 |
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Astrocytoma; Carcinoma, Adenoid Cystic; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melanoma; Middle Aged; Neurilemmoma; Optic Nerve Neoplasms; Orbital Neoplasms; Orbital Pseudotumor; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2008 |
Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain Neoplasms; Carbon Isotopes; Cell Division; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia, Brain; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Nitroimidazoles; Oligodendroglioma; Positron-Emission Tomography; Protons; Radiopharmaceuticals | 2010 |
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Everolimus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sirolimus; Temozolomide | 2011 |
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
Topics: Adult; Aged; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Prognosis; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
Topics: Brain Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2006 |
A prospective PET study of patients with glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy; Sample Size; Treatment Outcome | 2006 |
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Topics: Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2007 |
Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate; Teratoma; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
109 other study(ies) available for fluorodeoxyglucose f18 and Glioblastoma
| Article | Year |
|---|---|
First-in-human assessment of the novel LAT1 targeting PET probe
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Molecular Probes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2022 |
18F-Labeled WBC PET/CT Scan in a Case of Recurrent Glioblastoma Multiforme, Presented as Pyrexia of Unknown Origin.
Topics: Fever; Fever of Unknown Origin; Fluorodeoxyglucose F18; Glioblastoma; Humans; Leukocytes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Differentiating solitary brain metastases from glioblastoma by radiomics features derived from MRI and 18F-FDG-PET and the combined application of multiple models.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]Methionine.
Topics: Adrenal Cortex Hormones; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Vidarabine | 2022 |
Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma.
Topics: Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Glycolysis; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Male; Pyruvates; Rats; Rats, Wistar | 2023 |
What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Topics: Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Tomography, X-Ray Computed | 2023 |
Interesting Findings in 68 Ga-FAPI-46 PET/CT Imaging in a Patient With Glioblastoma Multiforme.
Topics: Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
Cervical Lymph Node Metastasis From Recurrent Glioblastoma Detected by MRI and 2-[18F]FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Superiority of [
Topics: Fluorodeoxyglucose F18; Glioblastoma; Humans; Methionine; Positron-Emission Tomography; Racemethionine; Radiopharmaceuticals | 2023 |
FDG PET/CT and MRI in Primary Spinal Cord Glioblastoma.
Topics: Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms | 2020 |
Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT.
Topics: Adolescent; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Neoplasm Metastasis; Neoplasm Staging; Neurons; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2020 |
Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Topics: Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Diazonium Compounds; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycolysis; Humans; Membrane Proteins; Radiopharmaceuticals; Sulfanilic Acids; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2021 |
FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Meningeal Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Spinal Cord Neoplasms; Temozolomide | 2021 |
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
Topics: Animals; Cell Line, Tumor; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Glioblastoma; Magnetic Resonance Imaging; Neoplasms, Experimental; Positron-Emission Tomography; Rats; Rats, Inbred F344 | 2021 |
Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Topics: Brain Neoplasms; Central Nervous System; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Positron-Emission Tomography; Retrospective Studies; Spin Labels | 2021 |
Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Injuries; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Usefulness of 18F-fluorodeoxyglucose-Positron Emission Tomography in Comparison with Methionine-Positron Emission Tomography in Differentiating Solid Hemangioblastoma from Adult Cerebellar Tumors.
Topics: Aged, 80 and over; Cerebellar Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Hemangioblastoma; Humans; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT?
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
[
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Temozolomide; Tissue Distribution; Treatment Outcome; Tumor Burden | 2019 |
[
Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Nude; Sensitivity and Specificity; Vidarabine | 2018 |
Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Coordination Complexes; Dendrimers; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms | 2018 |
Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Topics: Antineoplastic Agents; Brain Neoplasms; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Positron-Emission Tomography; Pyruvate Kinase; Radiopharmaceuticals; Tumor Cells, Cultured | 2020 |
Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Glioblastoma; Hepatocyte Growth Factor; Humans; Mice; Molecular Targeted Therapy; Positron-Emission Tomography; Time Factors; Xenograft Model Antitumor Assays | 2013 |
The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
Topics: Adolescent; Adult; Aged; Ammonia; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Young Adult | 2013 |
Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Brain Neoplasms; Dacarbazine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Injections, Intraventricular; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasms, Experimental; Temozolomide; Tomography, Emission-Computed; Treatment Outcome; Tumor Burden | 2013 |
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Positron-Emission Tomography; Rats; Survival Analysis | 2013 |
In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
Topics: Animals; Cell Line, Tumor; Chickens; Chorioallantoic Membrane; Disease Models, Animal; Drug Discovery; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Sodium Fluoride; Tomography, X-Ray Computed; Tumor Burden; Tyrosine | 2013 |
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Inbred F344; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2015 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
In vivo visualization of prostate-specific membrane antigen in glioblastoma.
Topics: Antigens, Surface; Fluorodeoxyglucose F18; Glioblastoma; Glutamate Carboxypeptidase II; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2015 |
A 66-year-old patient with progressive left hemiparesis: question.
Topics: Acute Disease; Aged; Brain Stem Neoplasms; Central Nervous System Infections; Cerebellar Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Encephalomyelitis; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
(68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Luminescence; Luminescent Measurements; Mice; Mice, Inbred BALB C; Oligopeptides; Optical Imaging; Organometallic Compounds; Peptides, Cyclic; Positron-Emission Tomography; Tissue Distribution | 2015 |
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2015 |
Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model.
Topics: Animals; beta-Alanine; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunohistochemistry; Male; Neoplasm Transplantation; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude | 2015 |
Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioblastoma; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Disease Models, Animal; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Humans; Image Processing, Computer-Assisted; Luminescent Measurements; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine | 2016 |
Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2016 |
The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
Topics: Animals; Brain; Cell Line, Tumor; Choline; Diagnosis, Differential; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kinetics; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2016 |
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Oxygen; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Virginia | 2017 |
Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Mice; Positron-Emission Tomography; Protein Kinases; Sirolimus; Thymidine; Thymidine Kinase; TOR Serine-Threonine Kinases; Tyrosine | 2008 |
Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas.
Topics: Boranes; Brain Neoplasms; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Phenylalanine; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric | 2008 |
FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Positron-Emission Tomography | 2008 |
PET of glial metabolism using 2-18F-fluoroacetate.
Topics: Animals; Brain Ischemia; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glioblastoma; Hypoxia-Ischemia, Brain; Male; Mice; Mice, Inbred C57BL; Neuroglia; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar | 2009 |
[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Topics: Acetates; Adolescent; Adult; Aged; Brain Abscess; Brain Neoplasms; Carbon; Carbon Radioisotopes; Child; Craniopharyngioma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2009 |
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Analysis; Survival Rate | 2009 |
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Synergism; Fluorodeoxyglucose F18; Glioblastoma; Humans; Luminescent Measurements; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2009 |
Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Survival Analysis | 2010 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Meningeal Neoplasms; Middle Aged; Positron-Emission Tomography; Spinal Cord | 2011 |
Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; ROC Curve | 2011 |
MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Topics: Animals; Brain Neoplasms; Disease Models, Animal; Dose Fractionation, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiation Injuries, Experimental; Radiation Tolerance; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Topics: Animals; Benzoates; Biological Transport; Cell Transformation, Neoplastic; Drug Stability; ErbB Receptors; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Mutation; Oligopeptides; Positron-Emission Tomography; Radioactive Tracers | 2011 |
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Young Adult | 2011 |
[Delineation of glioblastoma, simplicity to complexity, the contribution of imaging].
Topics: Carbon Radioisotopes; Central Nervous System Neoplasms; Clinical Trials as Topic; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methionine; Neoplasm Recurrence, Local; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Societies, Medical; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma.
Topics: Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography | 2011 |
Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays | 2012 |
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Middle Aged; Positron-Emission Tomography; Quality Control; Retrospective Studies; Young Adult | 2012 |
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2013 |
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Brain Neoplasms; Dacarbazine; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Imaging tumor burden in the brain with 89Zr-transferrin.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Mice, Inbred ICR; Radioisotopes; Transferrin; Tumor Burden; Zirconium | 2013 |
The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients.
Topics: Adult; Aged; Ammonia; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunocompetence; Lymphoma; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Glioblastoma; Humans; Macrophages; Monocytes; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured | 2003 |
[Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Topics: Adult; Animals; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Middle Aged; Sarcoma 180; Tomography, Emission-Computed; Tyrosine | 2002 |
Multicentric glioblastoma multiforme determined by positron emission tomography: a case report.
Topics: Aged; Biopsy; Dominance, Cerebral; Fluorodeoxyglucose F18; Frontal Lobe; Glioblastoma; Humans; Male; Neoplasms, Multiple Primary; Parietal Lobe; Postoperative Complications; Radiosurgery; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Characterization of 18F-FDG uptake in human endothelial cells in vitro.
Topics: Cell Line, Tumor; Cells, Cultured; Endothelium, Vascular; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Monocytes; Radionuclide Imaging; Radiopharmaceuticals; Sodium; Umbilical Veins | 2004 |
Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?
Topics: Cell Line, Tumor; Cells, Cultured; Endothelium, Vascular; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Monocytes; Radionuclide Imaging; Radiopharmaceuticals; Sodium; Umbilical Veins | 2004 |
[Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Topics: Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Thallium | 2005 |
Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.
Topics: Carcinoma, Small Cell; Cell Count; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2006 |
FDG PET of primary spinal glioblastoma initially mimicking a transverse myelitis on MRI.
Topics: Adolescent; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Myelitis, Transverse; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Spine | 2006 |
VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
Topics: Angiogenesis Inhibitors; Animals; Combined Modality Therapy; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Glioblastoma; Mice; Mice, Nude; Microcirculation; Neoplasm Proteins; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Dosage; Recombinant Fusion Proteins; Transplantation, Heterologous; Vascular Endothelial Growth Factors | 2007 |
Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; Drug Antagonism; Fluorodeoxyglucose F18; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Radiopharmaceuticals; Transplantation, Heterologous | 2008 |
[Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Glycolysis; Humans; Male; Meningioma; Middle Aged; Tomography, Emission-Computed | 1995 |
Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Radioimmunodetection; Sugar Acids; Technetium Tc 99m Pentetate; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Proteins; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.
Topics: Biological Transport, Active; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Survival Analysis; Tomography, Emission-Computed | 1993 |
Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Topics: Brain Neoplasms; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Topics: Aged; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Meningeal Neoplasms; Meningioma; Methionine; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Parietal Lobe; Tomography, Emission-Computed | 1996 |
Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Topics: Adult; Aged; alpha-Methyltyrosine; Amino Acids; Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase | 1997 |
Rapid rise in FDG uptake in an irradiated human tumour xenograft.
Topics: Animals; Apoptosis; Carcinoma, Small Cell; Deoxyglucose; Ependymoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Radiation Tolerance; Radionuclide Imaging; Tissue Distribution | 1997 |
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Spinal metastases of a high grade astrocytoma visualized with FDG-PET.
Topics: Adult; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, Emission-Computed | 1997 |
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Topics: Autoradiography; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Supratentorial Neoplasms; Tomography, Emission-Computed | 1998 |
Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Topics: Antineoplastic Agents, Hormonal; Blood Glucose; Brain; Dexamethasone; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Supratentorial Neoplasms; Tomography, Emission-Computed | 1998 |
Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
Topics: Astrocytoma; Blood Glucose; Brain Neoplasms; Cell Division; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Oligodendroglioma; Sensitivity and Specificity; Survival Rate; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Tenascin; Tomography, Emission-Computed | 1998 |
The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Topics: Adult; Aged; Astrocytoma; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Supratentorial Neoplasms; Survival Analysis; Tomography, Emission-Computed | 1998 |
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Topics: Astrocytoma; Brain; Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
Topics: Biological Transport; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Kinetics; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured | 1999 |
A cell-culture reactor for the on-line evaluation of radiopharmaceuticals: evaluation of the lumped constant of FDG in human glioma cells.
Topics: Bioreactors; Culture Media; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; In Vitro Techniques; Microscopy, Electron; Radiopharmaceuticals; Tumor Cells, Cultured | 2000 |
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2000 |
FDG-PET as a prognostic factor in high-grade astrocytoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2000 |
Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Topics: Adult; Aged; Animals; Astrocytoma; Brain Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Phenylalanine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.
Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Spinal Cord Neoplasms; Tomography, Emission-Computed | 1990 |
Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Tomography, Emission-Computed | 1989 |
Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1987 |
PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Topics: Astrocytoma; Brachytherapy; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Rubidium Radioisotopes; Tomography, Emission-Computed | 1988 |
Prediction of survival in glioma patients by means of positron emission tomography.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed | 1985 |
[In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Cerebrovascular Circulation; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Oligodendroglioma; Oxygen Consumption; Oxygen Radioisotopes; Tomography, Emission-Computed | 1986 |